Frank Karbe - May 29, 2024 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role: Director
Signature: /s/ Molly Henderson, Attorney-in-Fact for Frank Karbe
Stock symbol: PHAT
Transactions as of: May 29, 2024
Transactions value $: $254,113
Form type: 4
Date filed: 5/31/2024, 04:30 PM
Previous filing: May 24, 2024
Next filing: Dec 16, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PHAT	Common Stock	Award	$254K	+25K	+128.21%	$10.16	44.5K	May 29, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.1016 to $10.20. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.1016 to $10.20. The reporting person undertakes to provide Phathom Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.